Posted by Michael Wonder on 05 May 2020
WHO says it will engage US to make remdesivir coronavirus treatment more widely available
4 May 2020 - The WHO welcomes the recent data from a U.S. government-run clinical trial showing the drug appeared to be effective in reducing recovery times for COVID-19 patients, one official says.
The World Health Organization said Monday that it will speak with the U.S. government and Gilead Sciences on how antiviral drug remdesivir could be made more widely available to treat COVID-19 as data of its effectiveness emerges.
“We are grateful that the company Gilead and the director-general had direct discussions at the highest level to ensure that we had access to the remdesivir drug in order to launch the solidarity trials around the world,” Ryan said.
